Table 1. Clinical characteristics of the study groups.
| Variables | Control (n=111) | Obese (n=134) | p |
|---|---|---|---|
| Gender (% F) | 66 | 48 | 0.005 |
| Age (years) | 12.5±2.5 | 11.2±2.3 | <0.001 |
| BMI (kg/m2) | 18.8±2.6 | 27.0±4.5 | <0.001 |
| WC (cm) | 68.7±8.7 | 90.2±12.8 | <0.001 |
| SBP (mmHg) | 107.2±10.7 | 117.9±14.5 | <0.001 |
| DBP (mmHg) | 66.6±9.2 | 74.5±9.5 | <0.001 |
| Total cholesterol (mg/dL) | 134.2±28.6 | 150.3±40.7 | 0.001 |
| HDL-c (mg/dL) | 44.1±9.7 | 38.5±9.7 | <0.001 |
| LDL-c (mg/dL) | 73.7±21.1 | 91.8±33.1 | <0.001 |
| Triglycerides (mg/dL) | 74.1±27.1 | 92.0±44.9 | <0.001 |
| Glucose (mg/dL) | 82.3±10.5 | 86.6±9.4 | 0.001 |
| Insulin (µUI/mL) | 9.4±4.0 | 13.8±6.2 | <0.001 |
| HOMA-IR | 1.93±0.92 | 2.98±1.49 | <0.001 |
| Uric acid (mg/dL) | 3.50±1.12 | 4.47±1.13 | <0.001 |
F, female; M, male; BMI, body mass index; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; HDL, high-density lipoprotein; LDL, low-density lipoprotein; HOMA-IR, homeostatic model assessment for insulin resistance.